Member Info for HedgeHogarth

Whilst eating lunch, i thought I'd document Stu's roll of honour. He spends so much time on this forum, it felt like the least I could do to.

It was NOT fun: here's a few observations..

99.75% of his Posts were NEGATIVE or SCAREMONGERING

80% of his Posts involved arguing about timelines - very typical of a trader

He got something right and some things wrong - I will leave it with you to decide on the balance. Details below

Where STU was RIGHT:

Through Jan/Feb/March he was right to suggest the INF application was not imminent (although he continued this narrative right up until it was announced)

(yep, just the one)

Where STU Was WRONG

(brace yourselves)

I’m expecting other waffle on the use of the placing, how it will expand the trial and that’s why , we’ll be waiting god knows how long before the IND RNS. (21st April 2023)

Given the silence following the confirmation all Cart-T manufacturing completed successfully, i’m starting to think the word “Manufacturing” has a deeper significance. (13th April 2023)

I suspect it will be relatively soon that Hemo admits to the requirement for further work, possibly more than just additional quality runs, before they can submit Cart-T to the FDA (16th March 2023)

Let's land that Cart-T IND RNS and FDA clearance.

At that point, unfortunately for many, you'll have to suffer a round of my very positive and Hemo' complimenty post. (16th February, 2023)

Just for interest, I am expecting an RNS reach next week.

It will most probably be to deflect attention from the Cart-T IND delay onto some waffling progress in CBR. (12th February, 2023)

What I'm unfortunately expecting is deflection RNS's to take the spotlight off Cart-T followed by a belated and vague explanation of why the application/approval didn't proceed.

The company reputation and investor trust , depends on this particular advancement or failure and nothing else , regardless of hype. (6th February, 2023)

I wouldn’t be surprised the next news will be an appointment of sorts to assist in accelerating programs and a notch up in sp. (26th January, 2023)

After that I’m expecting disappointing news with the third party analysis requiring further PQ runs, with the sp dropping to around 1.7.

That’s when I’ll top up as i do believe there’s further potential but not in the short term (26th January, 2023)

The next RNS will be, problems with pre-qual runs and a requirement for more than the minimum (26th January, 2023)

The bigger question all should be asking is, what can you achieve with £4m !!!!

My guess, cover the general costs (nothing new) to try and fix problems yet to be announced on the road to IND. (26th January, 2023)

I’ll be adding after what i expect an announcement of more pre-qual work required before IND.

My view on the probability of the above transpiring…high! (24th January, 2023)

Questioned whether the FDA Pre IND Meeting actually went ahead (23rd January, 2023)

There you go STU THE SEALION in action

Go an MANIPULATE something else - NOBODY IS INTERESTED WHAT YOU HAVE TO SAY ON HERE

I do not believe a word you say STU - your history show that

(i'm sure the rest of the forum share my view)

MMS still quoting above the Bid for well over 1m shares

THEY WANT YOUR SHARES :-)

Mr India - careful my friend

JHFH is right - we all know that STU has an agenda, He is practising the art of SEA-LIONING

He or his associated are traders who care nothing about HEMO

Why give him the time of day - he'll only use the information for manipulative agenda.

We all DARE you STU to take another read of the RNS and playback to us all the great things they achieve in the FY2022 and summarise some of the potential upside that the CEO and Chairman are so excited about.

Ofcourse you wont

I'm no LIAR as you very well know STU THE MANIPULATOR

I do believe that HEMO are funded for the next 12 months AND i do expect them to complete Phase 1 in that same timeframe. We can agree to DISAGREE that the RNS suggest something different.

We can all see your attempts to focus on two or three words in a big RNS at twist them to create your negative narrative.

WE ALL SEE THROUGH YOU

I think i might name the next RNS - whether it's a positive CBR update or confirmation of FDA approval as the LIDL RNS in your honour - as you may have to start shopping there instead of Waitrose when you get caught short

Yep NNN has previously been in the hands of that Trevor guy at Braveheart - he seemed like a very dodg CEO doing all sorts of transactions that seemed to benefit him more than shareholders.

For the record....

I believe HEMO is undervalued NOW

The progress it has made in the last 6 months is huge.

In normal times, i think it the SP will have been much higher now that it is. I would have expected it to go up a bit more following IND submission. I would expect it to go up when IND gets the green ligtt from the FDA and if the next CBR update is positive i would expect the SP to go up.

BUT - things don't always play out to the timelines we expect. The re-rate could just as likely come before the FDA green light. Or it may come days or weeks after.

The beauty of being long in HEMO and an investor , not a trader, is that i stand to benefit whatever the timing.

Or ignore my posts and feast yourselves on the rubbish that get spewed by ONE2ONE and STU.

Sell your shares and give those guys a break so they or their paymasters can buy the shares at the price they want to pay

They only have a maximum of 10 days to achieve their objective - I'm sure those on this board are a charitable bunch, sell a few at 2.1 and let those guys back in.

Ooops - i also forgot to say that we could get an RNS at anytime on one of HEMO's other exciting developments - thats puts poor old STU and ONE2ONE under even more pressure

There - you have a choice guys.

(1) Feed STU and ONE2ONE

(2) Remember why you invested - trust the RNS, the FDA, HEMO's partners, HEMO's scientists who have been there and done it. And dont't worry about a few red trades here and there - at time like these those red trades are their to deceive.....

The market is in the doldrums - SO MANY shares are undervalued and HEMO is close to the top of that list.

I am confident that in the case of HEMO that will change soon and the share price will better reflect the significant progress and assets it has developed.

It HAS been a wonderfully successful year for #HEMO; It makes NO SENSE that it remains valued at this level when compared to it's peers.

(1) on the verge of clinical trials with CAR-T having moved premises, set up 2 safe rooms and successfully set-up, completed the manufacturing process to the standard demanded by FDA and submitted IND.

A maximum of 10 (Ten, Dix, Zehn, Diez) trading to go until the 30 day period is complete and HEMO will effectivle be a CLINICAL Biotech. (The only think stopping them is if FDA apply a clincial hold which they only do is about 1 in 20 occasions - most clinical holds are applied following adverse impacts to patients once trials have started)

(2) Futher demonstrated the potential of CBR / BME - a potentially game changing anti viral solution - in a class of its own - fully owned, protected and unique to #HEMO

(3) Raised £4m Cash to fund operations for at least 12mths - in a difficult market - at almost a +100% Premium to the prevailing share price in the previous 12mths

(4) And as of yesterday, the #HEMO market cap is up +60% YOY - This is a validation of their progress and this sets them apart from many of their peers

Good luck all

What a load of rubbish ONE2ONE - don't give up the day job

GREAT TRY STU - YOU DESPICABLE INDIVIDUAL

Luckily all on this forum know I am NOT a ramper or a liar

Hopefully Mr India will realise i don't mean to offend or dismiss any genuine concerns - It just disappoints me that as a genuine investor - he lets a few red trades have an impact. The MMs are playing games right now - if they look like a sell, they could just as easily be a buy. The rates are NOT a science - MMs can orchestrate a trade at ANY price they like. It does not have to be at the rate we see when we ask for a quote. SO PAYING SUCH CLOSE ATTENTION TO THE REPORTED TRADES IS PLAYING INTO THE HANDS OF MMs WHEN THEY ARE LOOKING TO DECEIVE.

I was NOT wrong about IND submission and I remain very confident that the IND will get FDA clearance within the 30 day period. There is a chance it may be slightly LESS than 30 days - BUT - the based on very clear FDA rules - Unless they place a clinical hold on the IND - Hemo are free to commence trials after 30 days.

Clinical holds are usually about safety to avoid harm to patients. DOES ANYONE REALLY THINK HEMO WILL NOT HAVE DONE EVERYTHING THEY CAN POSSIBLE DO TO ENSURE THE SAFETY IS RIGHT - If it is not safe, it will do a lot more harm that what our resident MANIPULATING TRADERS STU AND ONE2ONE do.

Nice that you put yourself in that same paragraph as those two - you are as bad as them filling up this forum with complete rubbish.

You are right, nobody will buy or sell on what you say. But you do make this forum a bad place to come.

Clearly you have or are selling again.

Good lucky with that 😘

Don't bother responding, I won't see it as I've just filtered you again.

Mr India, you are a fool.

Those that want the share price not to rise are looking for the exact reaction that you regularly give if you see a few red trades.

Do us all a favour and turn your PC off. Do some work

You and I have no idea if they were busy or sells of something in between to make them look like sells

I imagine if certain parties wanted people to think that people were selling, it would be relatively easy to make these transactions first thing. It's not a lot of volume and at what looks like a mid price

2023 -

These MANIPULATIVE DERAMPERS are like the SITH - there are always TWO

NOW WE HAVE ONE2ONE chirping in

What do we do?

We IGNORE IGNORE IGNORE (and maybe feel a little excited at how hard these FRAUDS are having to work to get you to sell or not buy share)

IGNORE IGNORE IGNORE

I did nothing of the sort - IGNORE STU THE MANIPULATIVE TRADER - STU THE NEGATIVE

As if anyone would ignore the FDA - #HEMO have done EVERYTHING in their power to ensure the IND moves into clinical trials in the normal timelines. (Pre IND meeting and followed all the FDA guidance word for word)

And if that is not enough, They are continuing to do so as part of a dialogue that naturally happens during this short period of review. People's lives are at stake - so FDA have to do their diligence

Welcome back @Senza - You look like an experiences trader/investor.

What's your story with #HEMO and what made you buy / top-up today?